Data showed that ALT activity (U/L) increased significantly in a fatty liver‐induced group (16.30 ± 1.84), while the dose of CB 250 mg (25.77 ± 10.51), CB 500 mg (15.85 ± 1.82), and CB 750 mg (11.28 ± 2.70) decreased significantly (*p < 0.05) the ALT value in comparison with the NCG (15.95 ± 1.03). The gene discussed is GPT; the disease is fatty liver disease.